In a crossover study, 12 healthy adults completed two 90-minute sessions after an overnight fast. In one session they received a continuous infusion of insulin (target plasma insulin 60 0 0pM) with euglycemic clamp (plasma glucose maintained at 5.0±0.2mM). In the other session they received saline. A microdialysis probe sampled interstitial fluid from vastus lateralis, and muscle biopsies were assayed for glycogen content. At 90 minutes, insulin increased whole-body glucose infusion rate required to maintain euglycemia, while plasma free fatty acids fell from 0.55 to 0.18mM. Which outcome is most consistent with insulin s integrated action on skeletal muscle metabolism during the clamp?
MCAT Biological and Biochemical Foundations of Living Systems Quiz
Practice 1d Metabolic Regulation Hormonal Integration in MCAT Biological and Biochemical Foundations of Living Systems with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.
This quiz focuses on 1d Metabolic Regulation Hormonal Integration, giving you a quick way to practice the rules, question types, and explanations that matter most for MCAT Biological and Biochemical Foundations of Living Systems.
Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.
In a crossover study, 12 healthy adults completed two 90-minute sessions after an overnight fast. In one session they received a continuous infusion of insulin (target plasma insulin 60 0 0pM) with euglycemic clamp (plasma glucose maintained at 5.0±0.2mM). In the other session they received saline. A microdialysis probe sampled interstitial fluid from vastus lateralis, and muscle biopsies were assayed for glycogen content. At 90 minutes, insulin increased whole-body glucose infusion rate required to maintain euglycemia, while plasma free fatty acids fell from 0.55 to 0.18mM. Which outcome is most consistent with insulin s integrated action on skeletal muscle metabolism during the clamp?
Explanation: This question tests understanding of insulin's integrated metabolic effects during a euglycemic clamp, specifically its action on skeletal muscle glucose metabolism. Insulin promotes anabolic processes by activating glucose uptake through GLUT4 translocation and stimulating glycogen synthesis while inhibiting lipolysis. During the euglycemic clamp, insulin levels are elevated while glucose is maintained constant through exogenous infusion, creating conditions that favor glucose storage. The correct answer (B) follows logically because insulin activates glycogen synthase through dephosphorylation via protein phosphatase 1, leading to increased muscle glycogen content when glucose is readily available. Choice A incorrectly suggests decreased GLUT4 translocation, which contradicts insulin's primary action of increasing glucose uptake. To verify insulin's anabolic effects, check whether the hormone promotes storage pathways (glycogen synthesis, lipogenesis) while suppressing catabolic pathways (lipolysis, glycogenolysis) - this principle applies across metabolic tissues.
Researchers study counterregulatory hormones during acute hypoglycemia. Participants receive an insulin infusion until plasma glucose reaches 2.8mM for 20 minutes. One group receives a nonselective 0 0-adrenergic blocker; the other receives placebo. In placebo, plasma lactate rises from 1.1 to 2.6mM and heart rate increases by 18 bpm; in the blocked group, heart rate does not change and lactate rises only to 1.5mM. Which outcome is most consistent with 0 0-adrenergic signaling s role in metabolic regulation during hypoglycemia?
Explanation: This question tests understanding of β-adrenergic signaling's role in counterregulatory responses during hypoglycemia. During hypoglycemia, epinephrine activates β-adrenergic receptors on skeletal muscle, stimulating glycogenolysis through cAMP/PKA signaling to increase lactate production for hepatic gluconeogenesis. The β-blocker prevents this response, explaining why lactate rises less in the blocked group compared to placebo. The correct answer (A) logically follows because β-blockade reduces muscle glycogenolysis, thereby decreasing lactate release into plasma. Choice B incorrectly suggests increased insulin secretion, which would worsen hypoglycemia rather than counteract it. To analyze counterregulatory responses, identify which hormones oppose insulin's actions (glucagon, epinephrine, cortisol, growth hormone) and their tissue-specific effects - this framework helps predict metabolic outcomes during stress states.
A biotech company tests a selective phosphodiesterase inhibitor (PDEi) in isolated human hepatocytes. Cells are treated with glucagon (10 nM) 0 0 0 for 15 minutes with or without PDEi. With glucagon alone, intracellular cAMP rises to 2.5-fold over baseline; with glucagon+PDEi, cAMP rises to 6.0-fold. Which downstream metabolic change is most consistent with adding PDEi in the presence of glucagon?
Explanation: This question tests understanding of cAMP signaling amplification and its metabolic consequences in hepatocytes. Phosphodiesterase (PDE) normally degrades cAMP, terminating glucagon signaling; PDE inhibition prolongs and amplifies cAMP accumulation, enhancing PKA activation and downstream phosphorylation events. With glucagon+PDEi producing 6-fold cAMP elevation versus 2.5-fold with glucagon alone, PKA activity is substantially increased, leading to enhanced phosphorylation of metabolic enzymes. The correct answer (C) accurately describes enhanced phosphorylation favoring glycogen breakdown, as PKA phosphorylates and activates phosphorylase kinase while inhibiting glycogen synthase. Choice B incorrectly suggests dephosphorylation, which would occur with insulin signaling, not enhanced cAMP/PKA activity. To predict PDE inhibitor effects, remember that they amplify existing cAMP-mediated signals rather than initiating new pathways - the metabolic outcome depends on which receptor (glucagon, β-adrenergic) is activated.
In an experiment on hormonal integration during feeding, subjects ingest a mixed meal (75 g carbohydrate, 25 g protein, 20 g fat). At 45 minutes, plasma glucose is 7.4mM and insulin is elevated. A subset receives an infusion of somatostatin to suppress pancreatic hormone secretion; basal replacement insulin is provided to maintain fasting insulin levels, but glucagon is not replaced. Compared with untreated controls, which outcome is most likely in the somatostatin group over the next hour?
Explanation: This question tests understanding of integrated pancreatic hormone effects on postprandial metabolism. During normal meal absorption, insulin rises to promote glucose uptake and storage while glucagon is suppressed, creating a high insulin:glucagon ratio that favors anabolism. Somatostatin suppresses both insulin and glucagon secretion; with only basal insulin replacement and no glucagon replacement, the insulin:glucagon ratio becomes abnormally low in the portal circulation. The correct answer (A) follows because reduced portal insulin and relatively unopposed glucagon action impairs the normal postprandial shift toward hepatic glycogen synthesis. Choice D incorrectly invokes incretin effects, but somatostatin's primary action here is on pancreatic hormones, not intestinal incretin secretion. When analyzing hormonal integration, consider both absolute hormone levels and their ratios - the insulin:glucagon ratio is particularly critical for determining whether the liver engages in glucose storage or production.
A patient with suspected Cushing syndrome undergoes an overnight dexamethasone suppression test, but cortisol remains elevated. The next morning, fasting plasma glucose is 7.1mM with elevated insulin. The clinician attributes hyperglycemia to cortisol s peripheral effects rather than reduced insulin secretion. Which outcome best explains cortisol s contribution to elevated fasting glucose in this case?
Explanation: This question tests understanding of cortisol's diabetogenic effects through peripheral insulin resistance and enhanced hepatic glucose production. Chronic cortisol excess promotes hyperglycemia by increasing hepatic gluconeogenic enzyme expression (PEPCK, G6Pase) while simultaneously inducing insulin resistance in muscle and adipose tissue, reducing glucose uptake. The elevated fasting glucose (7.1 mM) with elevated insulin indicates insulin resistance rather than insulin deficiency, consistent with cortisol's peripheral antagonism of insulin action. The correct answer (C) accurately describes both increased hepatic glucose production and reduced peripheral utilization, explaining the hyperglycemia despite elevated insulin. Choice A incorrectly suggests increased insulin sensitivity, which contradicts cortisol's well-established role in promoting insulin resistance. To analyze glucocorticoid effects, consider their tissue-specific actions: hepatic effects promote glucose production while peripheral effects oppose insulin-mediated glucose disposal.
During a 30-minute high-intensity cycling bout, a subject s plasma epinephrine rises from 0.2 to 1.6nM and plasma insulin decreases. Muscle ATP demand increases rapidly. Which process is most likely regulated by epinephrine to support immediate energy needs in skeletal muscle?
Explanation: This question tests understanding of epinephrine's acute metabolic effects during high-intensity exercise. Epinephrine binds β-adrenergic receptors on skeletal muscle, activating adenylyl cyclase to increase cAMP and activate PKA, which phosphorylates and activates glycogen phosphorylase for rapid glucose mobilization. During intense exercise with high ATP demand and low insulin, muscle requires immediate glucose from glycogenolysis rather than relying solely on blood glucose uptake. The correct answer (A) correctly identifies activation of glycogen phosphorylase as epinephrine's primary mechanism to meet acute energy needs. Choice D incorrectly places gluconeogenesis in skeletal muscle, but this process occurs primarily in liver and kidney, not muscle which lacks glucose-6-phosphatase. When analyzing exercise metabolism, distinguish between immediate fuel mobilization (phosphocreatine, glycogenolysis) and slower adaptive processes (increased blood flow, mitochondrial oxidation).
A patient with newly diagnosed type 2 diabetes has elevated fasting glucose (7.8 mM) and elevated fasting insulin. The clinician explains that the liver continues producing glucose despite insulin being present. Which hepatic process is most likely inappropriately active in this patient's fasting state?
Explanation: This question tests metabolic regulation and hormonal integration, addressing hepatic insulin resistance in type 2 diabetes. Hormones normally suppress fasting hepatic output, but resistance allows continued production despite insulin. In this vignette, elevated glucose and insulin connect to inappropriate hepatic activity. Gluconeogenesis and glycogenolysis contributing to increased hepatic glucose output (choice D) is active, reflecting insulin resistance. A common distractor, such as glycogen synthesis (choice B), fails as it's suppressed in fasting. To apply this, identify if resistance permits catabolic processes in high-insulin states. Confirm by assessing fasting labs for hepatic dysregulation.
A 35-year-old with an insulin-secreting pancreatic tumor has recurrent fasting hypoglycemia. During an episode, labs show: glucose 2.2 mM, insulin high, C-peptide high, and low plasma free fatty acids. The clinician explains that one reason symptoms occur rapidly is reduced availability of alternative fuels for the brain. Which process is most likely suppressed by the patient's hormonal state?
Explanation: This question tests metabolic regulation and hormonal integration, highlighting insulin's role in suppressing alternative fuel release during hypoglycemia. Hormonal control prioritizes glucose storage under high insulin, inhibiting catabolic processes like lipolysis to favor carbohydrate use. In this vignette, the insulinoma's high insulin suppresses lipolysis, leading to low free fatty acids and rapid symptoms from limited brain fuels. Adipose lipolysis, limiting fatty acid and glycerol release (choice B) is suppressed, reducing alternative fuels as high insulin inhibits hormone-sensitive lipase. A common distractor, such as increased hepatic gluconeogenesis (choice A), fails as high insulin suppresses, not promotes, this process. To apply this, identify if hyperinsulinemia restricts catabolic substrate release in hypoglycemic states. Verify by correlating low metabolites like FFAs with insulin-driven suppression.
Researchers perfuse isolated rat hepatocytes with either (i) insulin (10 nM) or (ii) epinephrine (1 µM) for 15 minutes, then add radiolabeled glucose and measure incorporation into glycogen. Incorporation is higher with insulin than with epinephrine, despite identical extracellular glucose (5 mM). Which process is most likely regulated in hepatocytes to account for the insulin condition?
Explanation: This question tests metabolic regulation and hormonal integration, emphasizing insulin's anabolic effects versus epinephrine's catabolic actions in hepatocytes. Hormonal control directs hepatic metabolism, with insulin promoting storage pathways like glycogenesis and epinephrine favoring breakdown. In this vignette, higher glycogen incorporation with insulin perfusion connects to its activation of synthetic enzymes despite identical glucose levels. Activation of glycogen synthase through dephosphorylation (choice A) logically accounts for increased incorporation, as insulin signaling dephosphorylates and activates the enzyme. A common distractor, such as inhibition of glucose uptake by decreasing GLUT4 (choice D), fails because hepatocytes use GLUT2, not GLUT4, and insulin promotes uptake. To apply this, differentiate hormone effects on enzyme phosphorylation in isolated cell models. Verify by comparing radiolabel incorporation rates to hormonal signaling pathways.
During a euglycemic insulin clamp, investigators infuse insulin while maintaining plasma glucose at 5.0 mM with variable glucose infusion. They observe that hepatic glucose output decreases markedly, even though hepatocytes do not rely on GLUT4 for glucose entry. Which mechanism best explains insulin's suppression of hepatic glucose output in this setting?
Explanation: This question tests metabolic regulation and hormonal integration, highlighting insulin's indirect suppression of hepatic glucose output. Hormones regulate liver metabolism via enzyme modulation, with insulin inhibiting gluconeogenesis without direct uptake effects. In this vignette, decreased output during clamp connects to insulin's signaling despite GLUT4 absence. Insulin decreases expression/activity of key gluconeogenic enzymes and promotes glycogen synthesis (choice D) explains suppression by shifting to storage. A common distractor, such as blocking export via GLUT4 (choice B), fails as liver uses GLUT2. To apply this, identify insulin mechanisms in non-GLUT4 tissues. Confirm by measuring output changes against infusion rates.
In a controlled feeding experiment, subjects consume a high-protein, low-carbohydrate meal. Plasma insulin increases modestly, and plasma glucagon increases substantially. Two hours later, plasma glucose remains stable near 4.9 mM. Which outcome is most consistent with the combined hormonal response to this meal?
Explanation: This question tests metabolic regulation and hormonal integration, focusing on glucagon and insulin's balance after high-protein meals. Hormones coordinate to convert amino acids to glucose while preventing excess rise, with glucagon driving gluconeogenesis. In this vignette, stable glucose with elevated glucagon and modest insulin connects to integrated hepatic control. Increased hepatic gluconeogenesis from amino acids while insulin limits excessive hyperglycemia (choice D) is consistent with the response. A common distractor, such as decreased hepatic production (choice B), fails as glucagon promotes it. To apply this, assess if meal composition elicits dual hormonal rises for stability. Confirm by tracking glucose against protein-induced hormone changes.
A research team compares two groups during a 12-hour fast: Group X receives an infusion that blocks pancreatic glucagon secretion; Group Y receives saline. At 12 hours, Group X has lower plasma glucose (3.6 vs 4.3 mM) and lower plasma urea nitrogen. Which interpretation best explains both findings in Group X?
Explanation: This question tests metabolic regulation and hormonal integration, examining glucagon's role in gluconeogenesis and amino acid catabolism. Hormones like glucagon drive hepatic substrate use, increasing urea from protein breakdown during fasting. In this vignette, lower glucose and urea with glucagon blockade connect to reduced hepatic catabolism. Reduced hepatic gluconeogenesis due to diminished glucagon signaling and reduced amino acid catabolism (choice A) explains findings, as glucagon promotes both. A common distractor, such as increased glycogen synthesis due to epinephrine (choice B), fails without epinephrine mention. To apply this, evaluate if hormone blockade lowers catabolic products like urea. Confirm by comparing glucose and nitrogen markers across groups.
A hospitalized patient receives a continuous dextrose infusion. When the infusion is abruptly stopped, plasma glucose falls from 6.0 to 3.9 mM over 20 minutes, and plasma epinephrine rises. The patient is not taking insulin. Which response is most likely mediated by epinephrine to restore plasma glucose?
Explanation: This question tests metabolic regulation and hormonal integration, examining epinephrine's counterregulatory role in restoring glucose after infusion stop. Hormones like epinephrine rapidly activate hepatic catabolism via cAMP to counteract falling glucose. In this vignette, glucose drop and epinephrine rise connect to adrenergic restoration without insulin. Increased hepatic glycogenolysis via cAMP signaling (choice A) is mediated by epinephrine to restore glucose. A common distractor, such as increased glycogen synthesis (choice B), fails as epinephrine promotes breakdown. To apply this, identify if catecholamines drive acute hepatic responses in glucose dips. Confirm by correlating epinephrine rises with glucose recovery.
A subject begins a 36-hour fast. At hour 6, insulin is low and glucagon is elevated; at hour 30, insulin remains low and glucagon remains elevated, but respiratory quotient decreases. The investigator interprets the later time point as increased reliance on lipid-derived fuels. Which change is most likely at hour 30 compared with hour 6, given the hormonal milieu?
Explanation: This question tests metabolic regulation and hormonal integration, focusing on prolonged fasting's shift to lipid metabolism under low insulin and high glucagon. Hormonal control adapts to fasting by promoting lipolysis and ketogenesis to spare glucose for the brain. In this vignette, decreasing respiratory quotient at hour 30 indicates greater lipid reliance, integrated with sustained glucagon elevation. Higher hepatic ketone body production due to increased fatty acid oxidation (choice A) is likely, as prolonged hormonal signals enhance ketogenesis. A common distractor, such as higher hepatic glycogen content (choice B), fails as glycogen depletes in fasting. To apply this, assess metabolic shifts by RQ changes in extended fasting. Verify if hormone persistence aligns with ketone elevation over time.
A study examines the effect of somatostatin infusion on counterregulation during mild hypoglycemia (plasma glucose clamped at 3.2 mM). Somatostatin lowers both insulin and glucagon secretion. Compared with control, subjects require a higher exogenous glucose infusion rate to maintain the clamp. Which best explains this observation?
Explanation: This question tests metabolic regulation and hormonal integration, highlighting somatostatin's suppression of pancreatic hormones during hypoglycemia. Hormonal balance in counterregulation relies on glucagon to boost hepatic output when insulin is low. In this vignette, higher infusion need with somatostatin connects to impaired endogenous production. Reduced endogenous hepatic glucose production due to suppressed glucagon despite low insulin (choice A) explains the observation, as glucagon is key for HGP. A common distractor, such as increased HGP (choice B), fails with suppressed glucagon. To apply this, evaluate if hormone suppression disrupts counterregulatory glucose maintenance. Confirm by comparing infusion rates to hormonal profiles.
A patient with adrenal insufficiency misses their glucocorticoid replacement and presents with fatigue and fasting hypoglycemia after an intercurrent illness. The clinician notes that catecholamines and glucagon are present but may be insufficient for sustained glucose maintenance. Which process is most likely reduced due to low cortisol, contributing to hypoglycemia?
Explanation: This question tests metabolic regulation and hormonal integration, addressing cortisol's support for sustained gluconeogenesis in stress. Hormones like cortisol upregulate enzymes and substrates for long-term glucose production during fasting or illness. In this vignette, hypoglycemia in adrenal insufficiency connects to deficient cortisol despite other counterregulators. Availability of gluconeogenic substrate and enzyme expression needed for sustained hepatic gluconeogenesis (choice A) is reduced, contributing to hypoglycemia. A common distractor, such as acute glycogenolysis by epinephrine (choice B), fails for sustained needs. To apply this, evaluate if steroid deficiency impairs prolonged counterregulation. Confirm by noting hypoglycemia timing with cortisol absence.
A lab measures hepatic enzyme phosphorylation states after treating mice with either insulin or glucagon for 30 minutes. In the glucagon-treated mice, the phosphorylated (inactive) form of glycogen synthase is increased. Plasma glucose rises by 0.8 mM. Which best explains the relationship between glucagon signaling and glycogen synthase activity in this context?
Explanation: This question tests the understanding of metabolic regulation through hormonal integration, specifically how glucagon modulates hepatic glycogen metabolism via phosphorylation cascades. Hormonal control in metabolism involves counterregulatory hormones like glucagon, which elevate blood glucose during fasting by promoting glycogenolysis and inhibiting glycogenesis through cAMP-mediated signaling pathways. In the vignette, glucagon treatment in mice leads to increased phosphorylation of glycogen synthase, rendering it inactive, which aligns with glucagon's role in shifting hepatic metabolism toward glucose release rather than storage. The correct answer, choice D, logically follows as glucagon activates protein kinase A via cAMP, phosphorylating glycogen synthase to inactivate it and thereby increasing plasma glucose as observed. A common distractor, such as choice B, fails because it incorrectly assumes glucagon promotes dephosphorylation and activation of glycogen synthase, which is actually an insulin-mediated effect via phosphatase activation. To apply this reasoning to similar scenarios, always recall that glucagon and insulin exert opposing effects on key metabolic enzymes through phosphorylation status. Additionally, verify hormonal effects by checking downstream outcomes like changes in plasma glucose levels to confirm the regulatory pathway.
A researcher administers a single dose of a long-acting somatostatin analog to healthy volunteers. Two hours later, after a mixed meal, plasma glucose rises to 9.0 mM (controls: 7.2 mM) despite similar meal composition. Which hormonal integration best explains the higher postprandial glucose in the treated group?
Explanation: This question tests understanding of somatostatin's role in coordinating postprandial glucose homeostasis. Somatostatin is a paracrine inhibitor that suppresses secretion of multiple hormones including insulin, glucagon, and GLP-1 from pancreatic and intestinal cells. By inhibiting insulin secretion with a somatostatin analog, the normal postprandial insulin response is blunted, reducing glucose uptake by peripheral tissues (muscle, adipose) and decreasing hepatic glucose storage as glycogen. The correct answer (D) logically explains the higher postprandial glucose through reduced insulin secretion and consequent impairment of glucose disposal. Answer B incorrectly suggests increased glucagon would increase hepatic glucose uptake, when glucagon actually promotes glucose release from liver. To understand integrated hormonal responses to meals, consider that insulin is the primary hormone for glucose disposal - blocking its secretion will impair the body's ability to clear absorbed glucose.
Participants with type 1 diabetes receive either (i) their usual basal insulin or (ii) a 30% higher basal insulin infusion overnight while maintaining identical carbohydrate intake. At 06:00, plasma glucose is 4.2 mM in condition (ii) vs 5.1 mM in condition (i). Plasma glucagon is higher in condition (ii). No exercise occurred. Which hepatic change best explains the counter-regulatory response observed in condition (ii)?
Explanation: This question tests understanding of counter-regulatory responses to insulin-induced hypoglycemia. When blood glucose falls below normal (as in condition ii with higher insulin), the body activates counter-regulatory mechanisms including glucagon secretion from pancreatic α-cells. Glucagon binds to hepatic receptors, activating adenylyl cyclase to increase cAMP, which activates PKA to phosphorylate and activate glycogen phosphorylase while inhibiting glycogen synthase. The correct answer (B) follows logically because the higher glucagon in response to lower glucose would stimulate hepatic glycogenolysis to restore euglycemia. Answer A incorrectly states that glucagon inhibits phosphorylase kinase, when it actually activates it through cAMP/PKA signaling. To analyze counter-regulatory responses, identify the stimulus (hypoglycemia), the hormonal response (increased glucagon, decreased insulin), and match the metabolic outcome to the hormone's known signaling pathway.
During a 60-minute moderate-intensity cycling bout, a subject's plasma insulin decreases from 8 to 3 µU/mL while plasma epinephrine increases from 0.2 to 1.1 ng/mL. Muscle biopsies show increased phosphorylation of glycogen phosphorylase. No exogenous glucose is provided. Based on the vignette, which outcome is most consistent with the hormonal integration during exercise?
Explanation: This question tests metabolic regulation and hormonal integration, particularly how catecholamines and insulin coordinate fuel supply during exercise. Hormonal control balances energy demands by decreasing insulin to reduce uptake and increasing epinephrine to promote hepatic glucose release. In this vignette, falling insulin and rising epinephrine during cycling integrate to support muscle via increased hepatic output, as shown by phosphorylated glycogen phosphorylase. Increased hepatic glycogenolysis and glucose output to support working muscle (choice B) follows logically from epinephrine's stimulation of liver catabolism amid low insulin. A common distractor, such as increased insulin-mediated suppression of adipose lipolysis (choice C), fails as insulin decreases during exercise, allowing lipolysis. To apply this, examine if hormonal shifts favor central fuel production over peripheral storage in energy-demanding states. Confirm by noting biomarkers like phosphorylase activation indicating catabolic dominance.